Prospective Double-blind Study for the Use of Aspirin During Transurethral Surgery of the Bladder or the Prostate

Prospektive Doppel-Blind-randomisierte Studie Zur Verwendung Von Aspirin Bei Transurethralen Operationen

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00861367

Enrollment

Registered

2009-03-13

Start date

2008-09-30

Completion date

2009-01-31

Last updated

2024-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Loss, Surgical, Intraoperative Complications, Re-operation Rates in Patients With Aspirin Treatment

Keywords

aspirin, blood loss, transurethral surgery

Brief summary

Aspirin is very common in older patients. Therefore many of the investigators patients have aspirin. The aim of the study is to proof that Transurethral Surgery of the bladder or the prostate can be performed with aspirin.

Interventions

DRUGtransurethral surgery with or without aspirin

aspirin 100mg once a day, transurethral surgery with or without aspirin

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

DOUBLE (Caregiver, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Transurethral surgery of the bladder or prostate, informed consent, age over 18

Exclusion criteria

* Oral anticoagulation,

Design outcomes

Primary

Measure	Time frame
Blood loss	intraoperative, 6 hours post op, 3 days postop

Secondary

Measure	Time frame
Reoperation rates	during hospitalization

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026